Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | TELA TELA Bio, Inc. | 13G | 11.12% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | GLUE Monte Rosa Therapeutics, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| PUBLIC INVESTMENT FUND | EA Electronic Arts Inc. | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| Oaktree Capital Holdings, LLC | STHO Star Holdings | 13G/A | 7.5% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | XFIN ExcelFin Acquisition Corp Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | PLYM Plymouth Industrial REIT, Inc. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Brave Warrior Advisors, LLC | PRI Primerica, Inc. | 13G/A | 6.03% | Dec 31, 2023 | 2y |
| Changlin Liang | DDL Dingdong (Cayman) Ltd | 13G/A | 26% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | TRNO Terreno Realty Corp | 13G | 5.1% | Dec 31, 2023 | 2y |
| HARRIS ASSOCIATES L P | CBRE Cbre Group, Inc. | 13G | 5.25% | Dec 31, 2023 | 2y |
| FPR PARTNERS LLC | ALIT Alight, Inc. / Delaware | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | ZYME Zymeworks Inc. | 13G/A | 0.04% | Dec 31, 2023 | 2y |
| NOMURA HOLDINGS INC | LHC Leo Holdings Corp. II | 13G/A | 0% | Dec 31, 2023 | 2y |
| MANGROVE PARTNERS IM, LLC | MREO Mereo BioPharma Group plc | 13G | 6.24% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | EQT EQT Corp | 13G | 12.9% | Dec 31, 2023 | 2y |
| GATE CITY CAPITAL MANAGEMENT, LLC | ALCO Alico, Inc. | 13G | 9.3% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | GLDD Great Lakes Dredge & Dock CORP | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| Ramaswamy Vivek | ROIV Roivant Sciences Ltd. | 13G/A | 9.75% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SDRL SEADRILL Ltd | 13G | 5.2% | Dec 31, 2023 | 2y |
| Gates Capital Management, Inc. | CCSI Consensus Cloud Solutions, Inc. | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Lincoln Park Capital Fund, LLC | WINT Windtree Therapeutics Inc | 13G/A | 6.18% | Dec 31, 2023 | 2y |
| Justin Rosenstein | ASAN Asana, Inc. | 13G/A | 13.6% | Dec 31, 2023 | 2y |
| SRB CORP | SAFT Safety Insurance Group Inc | 13G/A | 12.45% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | BDRX Biodexa Pharmaceuticals Plc | 13G/A | 0.94% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MGNX Macrogenics Inc | 13G/A | 7.37% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | CCB Coastal Financial Corp | 13G | 6.4% | Dec 31, 2023 | 2y |
| Lynx1 Capital Management LP | KNTE Kinnate Biopharma Inc. Common Stock | 13G/A | 4.2% | Dec 31, 2023 | 2y |
| 8 KNOTS MANAGEMENT, LLC | PNTG Pennant Group, Inc. | 13G | 6.14% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | FBRX Forte Biosciences, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | RDUS Radius Recycling, Inc. Class A Common Stock | 13G | 5.93% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | KYCH Keyarch Acquisition Corporation Ordinary Shares | 13G/A | 5.92% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | ITOS iTeos Therapeutics, Inc. Common Stock | 13G/A | 3.5% | Dec 31, 2023 | 2y |
| BlackRock Inc. | SOUN Soundhound Ai, Inc. | 13G | 5.6% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | EDR Endeavor Group Holdings, Inc. | 13G | 5.23% | Dec 31, 2023 | 2y |
| Hillhouse Investment Management, Ltd. | SGMT Sagimet Biosciences Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| Condire Management, LP | GATO Gatos Silver, Inc. | 13G | 8.3% | Dec 31, 2023 | 2y |
| Robert Nelsen | BEAM Beam Therapeutics Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| Capital V LLC | DSP Viant Technology Inc. | 13G | 64.7% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | DYN Dyne Therapeutics, Inc. | 13G/A | 3.26% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | URGN UroGen Pharma Ltd. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | MRTX Mirati Therapeutics, Inc. Common Stock | 13G | 0% | Dec 31, 2023 | 2y |
| MAIRS & POWER INC | TNC Tennant Co | 13G/A | 6.57% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | ASND Ascendis Pharma A/S | 13G/A | 6.5% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | KCGI Kensington Capital Acquisition Corp. V | 13G | 9.86% | Dec 31, 2023 | 2y |
| Blue Owl Capital Holdings LP | SYRS Syros Pharmaceuticals, Inc. Common Stock | 13G | 5.74% | Dec 31, 2023 | 2y |
| Lynrock Lake LP | TDC Teradata Corp | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| Russell C. Horowitz | MCHX Marchex Inc | 13G | 13.5% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | NVNO enVVeno Medical Corp | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | HMNF HMN Financial Inc | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | EDUC Educational Development Corp | 13G/A | 6.36% | Dec 31, 2023 | 2y |